Company / Interest Expense per Share
Bristol Myers Squibb Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.59
FY2023
5-year range
$0.38 / $0.63
FY2019-FY2023
Trend
-5.5%
vs FY2022
Sector context
#10 of 43
Health Care
What the data says
Bristol Myers Squibb's interest expense per share of $0.59 is higher than 77% of companies in the Health Care sector (FY2023). Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.10 in FY2018 to $0.87 in FY2020.
Based on SEC 10-K filings.
0.59 in FY2023 with a 5-year CAGR of +43.0%. Top quartile in the Health Care sector.
Increased from $0.38 to $0.59 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- +43.0%
- 10-Year CAGR
- -
Sector benchmark
-96.8% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 5.5% year-over-year.
- Ranks #10 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2020.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.59 | -5.5% |
| FY2022 | $0.63 | +64.1% |
| FY2021 | $0.38 | -55.8% |
| FY2020 | $0.87 | +631.1% |
| FY2019 | $0.12 | +19.4% |
| FY2018 | $0.10 | -14.8% |
| FY2017 | $0.12 | -4.0% |
| FY2016 | $0.12 | +1.5% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026